Drott C, Göthberg G, Claes G
Department of Surgery, Borås Hospital, Sweden.
J Am Acad Dermatol. 1995 Jul;33(1):78-81. doi: 10.1016/0190-9622(95)90015-2.
Hyperhidrosis of the palms, axillae, and face has a strong negative impact on the quality of life for many persons. Existing nonsurgical therapeutic options are far from ideal. Definitive cure can be obtained by upper thoracic sympathectomy. The traditional open surgical technique is a major procedure; few patients and doctors have found that risk-benefit considerations favor surgery. Endoscopic minimal invasive surgical techniques are now available.
We investigated whether endoscopic ablation of the upper thoracic sympathetic chain is efficient and safe in the treatment of hyperhidrosis.
We treated 850 patients with bilateral endoscopic transthoracic sympathectomy.
There was no mortality or life-threatening complication. Nine patients (1%) required intercostal drainage because of hemothorax or pneumothorax. Treatment failure occurred in 18 cases (2%) and symptoms recurred in 17 patients (2%). At the end of follow-up (median, 31 months) 98% of the patients reported satisfactory results.
Endoscopic transthoracic sympathectomy is an efficient, safe, and minimally invasive surgical method for the treatment of palmar, axillary, and facial hyperhidrosis.
手掌、腋窝和面部多汗症对许多人的生活质量有严重负面影响。现有的非手术治疗方法远非理想。胸上段交感神经切除术可实现根治。传统的开放手术技术是一种大型手术；很少有患者和医生认为风险效益比有利于手术。现在有了内镜微创外科技术。
我们研究了内镜下胸上段交感神经链消融术治疗多汗症是否有效和安全。
我们对850例患者进行了双侧内镜经胸交感神经切除术。
无死亡或危及生命的并发症。9例（1%）患者因血胸或气胸需要肋间引流。18例（2%）治疗失败，17例（2%）症状复发。随访结束时（中位时间31个月），98%的患者报告结果满意。
内镜经胸交感神经切除术是治疗手掌、腋窝和面部多汗症的一种有效、安全且微创的手术方法。
